Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
about
Enzymes of the cyclooxygenase pathways of prostanoid biosynthesisHuman cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimerImpairment of aspirin antiplatelet effects by non-opioid analgesic medicationEndocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathwaysStructural Basis for L-Lysine Feedback Inhibition of Homocitrate SynthaseComparison of Cyclooxygenase-1 Crystal Structures: Cross-Talk between Monomers Comprising Cyclooxygenase-1 Homodimers,Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxibPrediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling.Chemically Aware Model Builder (camb): an R package for property and bioactivity modelling of small moleculesMass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseMolecular basis of cyclooxygenase enzymes (COXs) selective inhibitionAspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages.Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids.An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals.Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs.Etoricoxibium picratePrevention of upper gastrointestinal haemorrhage: current controversies and clinical guidanceAction at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.Prospective performance evaluation of selected common virtual screening tools. Case study: Cyclooxygenase (COX) 1 and 2.Classification of scaffold-hopping approachesHuman cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids.Decreased cyclooxygenase inhibition by aspirin in polymorphic variants of human prostaglandin H synthase-1.Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis.Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.Mechanistic and pharmacological issues of aspirin as an anticancer agent.Computational Drug Target Screening through Protein Interaction Profiles.Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity.Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscsCelecoxib for the treatment of atherosclerosis.Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.[Unexpected hemorrhage complications in association with celecoxib. Spontaneously reported case series after perioperative pain treatment in gynecological operations].Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.Toward the understanding of the molecular basis for the inhibition of COX-1 and COX-2 by phenolic compounds present in Uruguayan propolis and grape pomace.Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
P2860
Q24630614-D70D8F8D-F43C-4624-9422-ACF6C4D8F9EEQ24632466-75DECCD3-6A5D-4B86-A8A9-89FA85DE8094Q26801633-94490AD9-763B-4CEF-AF64-C8E3845C9DB4Q26823256-FF4DC7DB-1068-4C3E-8560-BBC5A971E3DCQ27659064-5FE00DEA-8F32-44E4-BC8E-355BD4E65A1DQ27663665-0F6BAB9C-91CB-4F33-97F8-D9C6BD9006F6Q27673277-5DCDFD65-FFA0-4D5C-9736-CEB76A9A93BCQ27675386-470CE757-6561-4B00-A941-E67D20EC4F67Q27680024-9BCA2983-3283-420C-8699-1C750378F3E0Q27902278-3294A204-B34E-4DAC-9F17-62ECD32451A5Q27902305-EC6CB136-3E09-433D-A66C-6075ACDF3BEAQ28075372-93F64A5B-BF38-4AEE-A871-E48FD4656F08Q33777769-E68D372F-7494-4BF9-BB4C-7CB803AACFF5Q33873763-C035BF62-496B-4058-BAFD-304BD5EC38ABQ33890830-08B06CA0-3B5C-4348-AA26-FB707ECBF7FFQ34190368-64C0B2A6-C270-485B-BFFB-920BF284A18AQ34601141-A9D805C7-CAD6-42E6-95E7-DE2131A9614BQ34631609-E7A296BF-8394-4C04-A6C0-FAA843B6309DQ34655792-62BD421D-A55D-4538-8F3E-3E2E84E04F8CQ35608133-68478D6F-B7D9-4D6F-BF42-AC7729D48E0AQ35615893-0BB11EA0-485C-417F-AC11-3BCBDDC04E2BQ35893996-3A408307-4073-4A5B-865B-CB96B1A4CCACQ36020274-B0D2FACC-27C0-4F11-8EDE-5754978EC013Q36035412-4C9A1244-FEBA-47EF-A9A7-83CD990DA364Q36594702-D6FC949F-0B7A-40A8-8C97-DC423DB3ED10Q36642779-78121E63-0033-4DBA-BB12-A5AADB4E8535Q36802113-722921DB-90C8-49A7-A564-5185AD2CA683Q37213786-94E7EFE5-9A63-461E-80AA-8B5CAD83775EQ37277350-02798EE1-D252-4A81-B206-0A1A42B19012Q37414273-121EF9B8-D9CC-4B38-BE55-2590B35DD5CBQ38218184-589A651A-7A83-4941-B18F-03C36088942CQ38259405-F8BED0F0-986A-4D48-A671-B84DC7E11423Q38540681-A7015597-7178-46B7-BDCF-3D94AA9D2EA8Q38759585-0CA40F5F-40E1-4D83-8CEB-6AFA87E0D1B7Q38968695-6E28831F-35AB-46DB-9C5F-E8C6108FA55EQ41701311-C066507D-F5A2-4A2D-BB62-46B0D5A77D79Q43934192-61F2CCED-DCA3-4901-BE36-544C76871F9AQ46353525-257179EC-2F83-4FC9-BB19-DC97E1CAFCC7Q46633283-88A50D7A-D0AC-428F-8C87-862D8B6F1F25Q51718607-7EF6EB7C-92BE-4B83-B9BD-C4525E3ABBB1
P2860
Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@ast
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@en
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@nl
type
label
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@ast
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@en
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@nl
prefLabel
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@ast
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@en
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@nl
P2093
P2860
P3181
P356
P1476
Coxibs interfere with the acti ...... ne monomer of cyclooxygenase-1
@en
P2093
Benedict R Lucchesi
Chong Yuan
D Adam Lauver
Gilad Rimon
Jullia Y Lee
Narayan P Sharma
Ranjinder S Sidhu
Raymond C Trievel
Ryan A Frieler
William L Smith
P2860
P3181
P356
10.1073/PNAS.0909765106
P407
P577
2010-01-05T00:00:00Z